Inari Medical Inc. logo

Inari Medical Inc. (NARI)

Delisted
19 Feb 2025
NASDAQ (NGS) NASDAQ (NGS)
$
79. 97
0
0%
$
2.24B Market Cap
- P/E Ratio
- Div Yield
0 Volume
-0.56 Eps
$ 79.97
Previous Close
Investors:
Day Range
79.97 79.97
Year Range
36.73 79.99
Want to track NARI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Shareholders that lost money on Inari Medical, Inc.(NARI) should contact Levi & Korsinsky about pending Class Action - NARI

Shareholders that lost money on Inari Medical, Inc.(NARI) should contact Levi & Korsinsky about pending Class Action - NARI

NEW YORK, NY / ACCESSWIRE / June 26, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Levi & Korsinsky Reminds Inari Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024 - NARI

Levi & Korsinsky Reminds Inari Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024 - NARI

NEW YORK, NY / ACCESSWIRE / June 26, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Investors Who Have Suffered Losses In Inari Medical Inc Are Urged By The Schall Law Firm To Establish Communication As It Initiates An Investigation

Investors Who Have Suffered Losses In Inari Medical Inc Are Urged By The Schall Law Firm To Establish Communication As It Initiates An Investigation

LOS ANGELES, CA / ACCESSWIRE / June 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.

Accesswire | 2 years ago
Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NARI

Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NARI

NEW YORK, NY / ACCESSWIRE / June 26, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Levi & Korsinsky Reminds Inari Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024 - NARI

Levi & Korsinsky Reminds Inari Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024 - NARI

NEW YORK, NY / ACCESSWIRE / June 26, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
NARI LAWSUIT ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NARI LAWSUIT ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, NY / ACCESSWIRE / June 26, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Inari Medical, Inc. - NARI

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Inari Medical, Inc. - NARI

NEW YORK, NY / ACCESSWIRE / June 26, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Inari Medical, Inc. ("Inari" or the "Company") (NASDAQ:NARI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Accesswire | 2 years ago
Shareholders That Lost Money on Inari Medical, Inc.(NARI) Should Contact Levi & Korsinsky About Pending Class Action - NARI

Shareholders That Lost Money on Inari Medical, Inc.(NARI) Should Contact Levi & Korsinsky About Pending Class Action - NARI

NEW YORK, NY / ACCESSWIRE / June 26, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Shareholders That Lost Money on Inari Medical, Inc.(NARI) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Shareholders That Lost Money on Inari Medical, Inc.(NARI) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

NEW YORK, NY / ACCESSWIRE / June 26, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Investors Who Have Incurred Losses In Inari Medical Inc Are Encouraged By The Schall Law Firm To Begin Communication As It Starts A Probe

Investors Who Have Incurred Losses In Inari Medical Inc Are Encouraged By The Schall Law Firm To Begin Communication As It Starts A Probe

LOS ANGELES, CA / ACCESSWIRE / June 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.

Accesswire | 2 years ago
Here's Why You Should Retain Inari Medical (NARI) for Now

Here's Why You Should Retain Inari Medical (NARI) for Now

Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.

Zacks | 2 years ago
Levi & Korsinsky Notifies Shareholders of Inari Medical, Inc.(NARI) of a Class Action Lawsuit and an Upcoming Deadline

Levi & Korsinsky Notifies Shareholders of Inari Medical, Inc.(NARI) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, NY / ACCESSWIRE / June 25, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Loading...
Load More